System Maintenance Notice

Please note that maintenance work is scheduled between 4 AM and 5 AM - CET. During this time, you may experience reduced performance. Thanks for your patience.

Silvia Papa is an expert in Cardiology at Policlinico Umberto I (Italy). Silvia Papa has authored 95 publications, the most recent in 2026, and is an investigator in 1 clinical trial, 1 of them ongoing. SLR score: 271 (community average: 125). How the SLR is computed.

LeadR Profile

Silvia Papa Policlinico Umberto I Italy
271 ScienceLeadR Reputation 271

Unlock

Register Login
Network Map

Cardiology

Subspecialties: Pharmacy - Pulmonology - Transplantation

Full career – Last 3 years

Main Topics

Publications and Clinical Studies

Publications – Clinical Studies

Profile data updated on

Expert Rankings

Top experts on the MeSH terms this expert works on

Organizations

Career arc: 2013 - 2026
Source: PubMed

Sapienza University of Rome

Publications Synthesis

Sources: PubMed, OpenAlex

Number : 95

Citations

Citations: 1 410 1st author: 5 Last author: 2 Unique author: 0

Main journals

J Heart Lung Transplant 19
Int J Cardiol 9
Eur Heart J Suppl 8
Vascul Pharmacol 8
J Clin Med 5

Best Journals

Am J Respir Crit Care Med 1
Eur Heart J 1

Breakdown by type

Click a legend label to hide or show it in the chart.

Latest Publications

5 most recent indexed articles

Source: Pubmed

Title Journal Year Citations
Treatment of acute pulmonary embolism: anticoagulation, fibrinolysis, and thrombectomy compared.
PMID 42099499 — embolism, fibrinolysis, pulmonary embolism, therapeutics, thrombectomy		Eur Heart J Suppl20260
Initial combination of macitentan with riociguat in the treatment of pulmonary arterial hypertension.
PMID 42031021 — hypertension, pulmonary arterial hypertension, therapeutics		Chest20260
2025 expert consensus on the use of parenteral prostanoids in incident and prevalent PAH patients: The Italian perspective.
PMID 41765197 — ventricular dysfunction, ventricular dysfunction, right, prostaglandins, pharmacology, physicians, therapeutics		Vascul Pharmacol20260
Value of right heart haemodynamics for risk stratification of patients with pulmonary arterial hypertension at follow-up.
PMID 41711746 — hypertension, stroke, heart failure, heart, pulmonary arterial hypertension, stroke volume, atrial pressure		ESC Heart Fail20260
Pulmonary arterial hypertension: right ventricular phenotyping to improve risk assessment at follow-up.
PMID 41649944 — hypertension, risk assessment, phenotype, cardiology, pulmonary arterial hypertension		Eur Heart J Top journal20260

Clinical Studies 1

Sources: ClinicalTrials, EU CTIS

Synthesis

By phase:

Phase 3 1

By status:

Not yet recruiting 1

By type:

Interventional 1

By Monocentric/Multicentric:

monocentric 0
multicentric2to4 0
multicentric5to9 0
multicentricup10 1

Main Topics

Ongoing Clinical Trials

Ongoing trial started since 2021, where this expert is an investigator

Source: ClinicalTrials

Study Phase Status Start
A clinical study to test how safe and effective a new inhaled treatment (called L606) is for people with high blood pressure in the lungs due to interstitial lung disease
2024-517943-29-00 — hypertension, lung, hypertension, pulmonary, safety, blood, suspensions, liposomes, blood pressure, inhalation, therapeutics, lung diseases, lung diseases, interstitial		Phase 3Not yet recruiting2026

LeadR Networks

Main global connection map

Sources: PubMed, OpenAlex, ClinicalTrials, EU CTIS